Mode
Text Size
Log in / Sign up
Phase 4 N=32 Randomized Single-blind Treatment

Effect of Injectable Platelet-Rich Fibrin (i-PRF) in Initial Treatment of Chronic Periodontitis

Periodontitis

Enrolled (actual)
32
Serious AEs
Results posted
Jun 2020
Primary outcome: Primary: Periodontal Pocket Depth-PPD — 3.735; 3.696 mm — p=0.429

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
SRP + Injectable Platelet-Rich Fibrin (Drug); SRP + placebo (Drug)
Age
Adult, Older Adult · 20+ yrs
Sex
All
Sponsor
University of Belgrade
Primary completion
Jun 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Periodontal Pocket Depth-PPD
3.735; 3.696 0.429
PRIMARY
Periodontal Pocket Depth-PPD - 1m
2.398; 2.876 0.000 sig
PRIMARY
Periodontal Pocket Depth-PPD - 3m
1.990; 2.567 0.000 sig
PRIMARY
Periodontal Pocket Depth-PPD - 6
1.778; 2.409 0.000 sig
PRIMARY
Level of Gingival Margin-LGM
1.737; 1.787 0.575
PRIMARY
Level of Gingival Margin-LGM - 1m
0.948; 1.150 0.575
PRIMARY
Level of Gingival Margin-LGM - 3m
0.782; 0.877 0.249
PRIMARY
Level of Gingival Margin-LGM - 6m
0.808; 0.794 0.871
PRIMARY
Clinical Attachment Level- CAL
2.009; 2.018 0.773
PRIMARY
Clinical Attachment Level- CAL - 1m
1.453; 1.755 0.000 sig
PRIMARY
Clinical Attachment Level- CAL - 3m
1.237; 1.619 0.000 sig
PRIMARY
Clinical Attachment Level- CAL - 6m
1.226; 1.585 0.000 sig
PRIMARY
Bleeding on Probing-BOP
1.418; 1.345 0.063
PRIMARY
Bleeding on Probing-BOP - 1m
0.649; 1.005 0.000 sig
PRIMARY
Bleeding on Probing-BOP 3m
0.298; 0.601 0.000 sig
PRIMARY
Bleeding on Probing-BOP - 6m
0.098; 0.257 0.000 sig
PRIMARY
Plaque Index- PI
1.231; 1.241 0.085
PRIMARY
Plaque Index- PI -1m
0.255; 0.250 0.000 sig
PRIMARY
Plaque Index- PI -3m
0.236; 0.212 0.000 sig
PRIMARY
Plaque Index- PI - 6m
0.199; 0.203 0.895
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF)
24; 24; 6; 6 0.999
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) -1m
5; 18; 25; 12 0.000 sig
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) - 3m
8; 16; 22; 14 0.008 sig
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) - 6m
17; 19; 13; 11 0.500
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF)
30; 30; 0; 0 0.999
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 1m
12; 28; 18; 2 0.000 sig
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 3m
21; 27; 9; 3 0.40
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 6m
28; 29; 2; 1 0.999
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF)
27; 27; 3; 3 0.999
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) -1m
12; 23; 18; 7 0.001 sig
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) - 3m
17; 20; 13; 10 0.453
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) -6m
22; 24; 8; 6 0.625
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF)
24; 24; 6; 6 0.999
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 1m
7; 23; 23; 7 0.000 sig
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 3m
11; 24; 19; 6 0.001 sig
PRIMARY
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 6m
17; 24; 13; 6 0.065
PRIMARY
Periodontal Pocket Microorganisms
2408369.00; 2372881.00 0.821
PRIMARY
Periodontal Pocket Microorganisms -1m
27708.86; 323142 0.000 sig
PRIMARY
Periodontal Pocket Microorganisms - 3m
825098.93; 226048.10 0.001 sig
PRIMARY
Periodontal Pocket Microorganisms - 6m
71493.73; 336812.27 0.000 sig
PRIMARY
Tumor Necrosis Factor Alpha-TNF-α
0.925; 0.918 0.000 sig
PRIMARY
Tumor Necrosis Factor Alpha-TNF-α -1m
0.382; 0.782 0.000 sig
PRIMARY
Tumor Necrosis Factor Alpha-TNF-α - 3m
0.259; 0.587 0.000 sig
PRIMARY
Tumor Necrosis Factor Alpha-TNF-α -6m
0.238; 0.456 0.000 sig
PRIMARY
Matrix Metalloproteinase 8 - MMP-8
11.315; 11.336 0.671
PRIMARY
Matrix Metalloproteinase 8 - MMP-8 -1m
7.906; 9.964 0.000 sig
PRIMARY
Matrix Metalloproteinase 8 - MMP-8 - 3m
6.010; 9.061 0.000 sig
PRIMARY
Matrix Metalloproteinase 8 - MMP-8 - 6m
4.681; 8.642 0.000 sig
PRIMARY
Alkaline Phosphatase - ALP
280.496; 280.852 0.753
PRIMARY
Alkaline Phosphatase - ALP -1m
116.936; 199.666 0.000 sig
PRIMARY
Alkaline Phosphatase - ALP -3m
145.716; 216.835 0.000 sig
PRIMARY
Alkaline Phosphatase - ALP -6m
237.554; 268.905 0.000 sig

Summary

Current treatments of periodontitis have limited efficacy since they fail to suppress microorganisms satisfactorily over time. The aim of present study was to investigate whether there are differences between initial treatment of chronic periodontitis (SRP) and SRP in conjunction with injectable platelet-rich fibrin (i-PRF) application.

Eligibility Criteria

Inclusion Criteria

  • A minimum of 6 teeth per quadrant;
  • A minimum of 2 teeth in each quadrant with a probing depth (PD) ≥5 mm;
  • Bleeding on probing (BOP) had to be at ≥40% tooth sites;
  • No involvement of furcation;
  • Good general health.

Exclusion Criteria

  • Periodontal therapy within last 12 months;
  • Having surgical therapy;
  • Use of antibiotics over the last 6 months;
  • Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis;
  • Pregnancy or nursing;
  • Current and former smokers.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04178590). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search